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Background:  It has been shown that circulating endothelial progenitor cells (EPC’s) increase following myocardial infarction and that they are 
involved in new blood vessel formation; thus the development of collateral circulation (CC) following infarction may be related to the number of 
circulating EPC’s. 
Objective: To determine the correlation between circulating EPC’s and CC in patients with Coronary Artery Disease.
Methods:  The EPC’s and Mature Endothelial Cells (MEC’s) were determined by cytometry in peripheral blood of pts. with no CAD, as determined by 
a normal Coronary CT (n=13), and patients with CAD as determined by Coronary Catheterization ( > 2 obstructed vessels; n=21). Severity of CAD and 
degree of CC were determined by the SYNTAX and Cohen-Rentrop scores. Data was analyzed using X2, Fisher’s exact test, t-Student test or Pearsons’s 
r. EPC’s were catogorized as “early” (CD133+, CD34+ and KDR+), intermediate (CD133-, CD34+ and KDR+), MEC (CD133-, CD34-, KDR+, CD146+) 
and “monocytic profile” EPC (CD34+, KDR+ and CD14+).
Results:  No difference was found between groups, except for age (Median: 48 (range: 22-65) vs. 63 (range: 47-82) years respectively; p<0.001. 
The absolute “early” and “intermediate” EPC’s number in control group was higher than CAD (mean: 48.5 + 24.3 vs. 30 + 15, p<0.03 and 44 + 
17.5 vs. 29 + 15.6, p<0.02; respectively), but no differences were observed in MEC’s control and CAD groups (15 + 6.7 vs. 11.7 + 8.3, p=0.19; 
respectively). Although, no differences were found between EPC’s cells and the Synthax score (n=15; r: =0.98, p=0.007), we found a trend between 
Cohen-Rentrop scores and EPC’s numbers (n= 12; r=0.476, p<0.059; OR=7 (CI95%: 0.37 to 123). When we analyzed “monocytic profile” EPC, we 
found a statistically significant difference in the control group than that of the CAD group (Mean 40± 12.5 vs. 25±9.2, p<0.026; respectively).
Conclusion: These data suggests that higher numbers of circulating EPC are associated with an increased degree of CC in patients with CAD, 
suggesting that identification of signals that stimulate bone marrow release of EPC’ s may provide a new therapeutic target. Further studies in a 
larger population are warranted.
